HOME > BUSINESS
BUSINESS
- 21 Japan Drug Makers’ Combined Sales Up 5% in FY2018, but Flagging Japan Biz Continues
May 16, 2019
- Daiichi Sankyo’s Quizartinib Voted Down by US FDA Advisory Committee
May 16, 2019
- Yutaka Ogihara, Grandson of Founder Hiroshi Ogihara, to Lead Kyorin Holdings
May 16, 2019
- Takeda Sees 18.5% Sales Rise after Shire Buy, but Braces for Losses in FY2019
May 15, 2019
- Nichi-Iko Aims at Overseas Sales of 60 Billion Yen in FY2021; Infliximab Biosimilar in the US to Play Key Role
May 15, 2019
- AnGes Delays Launch of Collategene, “Sale Preparations Will Take More Time”
May 15, 2019
- Nichi-Iko Reduces Its Stake in Aprogen, Biz Tie-Up to Stay
May 14, 2019
- US PII Study for Telomelysin-Keytruda Combo Begins for Esophageal Cancer
May 14, 2019
- Nichi-Iko Aims to Resume Stable Supply of Cefazolin by Year-End: Exec
May 14, 2019
- Avastin Top Selling Drug in Japan in April: Encise Snapshot
May 14, 2019
- Japan Ethical Drug Sales Up 0.5% in March: Crecon
May 14, 2019
- Kyorin Grabs Japan Negotiation Rights to Marketing Collaboration for MSD’s Cough Treatment
May 14, 2019
- Daiichi Sankyo’s Hypertension Drug Minnebro Now Available
May 14, 2019
- Eisai’s FY2018 Net Profit Jumps 22.3% on Merck Deal, Global Brands
May 14, 2019
- Sumitomo Dainippon’s Sales Down 1.6% on Price Cuts, Generic Erosions
May 13, 2019
- Sunovion to Push Different Dasotraline Trial Data in FDA Negotiations: Sumitomo Dainippon Chief
May 13, 2019
- Mitsubishi Tanabe Foresees 82% Profit Dip in FY2019 as Gilenya Feud Weighs
May 13, 2019
- 70% of Drug Makers Shave New Grad Hiring, 100-Plus Recruits at Only 3 Firms: Jiho Survey
May 13, 2019
- Eisai Nabs Japan Distribution Rights to MTX SC Injection
May 13, 2019
- Alzheimer's Consortium Selects Elenbecestat, BAN2401 for Prevention Studies
May 13, 2019
ページ
On paper, things should be looking up for Japan’s pharmaceutical wholesalers. Industry expectations are mounting that the average gap between NHI and market prices will narrow further in FY2026 from the previous year’s record low of 4.8%.A shrinking gap should…
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
